leisure time -WSS

leisure time

author：focus 2025-09-30 04:34:49 - browse：6

Priscilla Chan and Mark Zuckerberg on stage, virtually, at the 2023 STAT Summit. — Priscilla Chan and Mark Zuckerberg appear virtually at the 2023 STAT Summit. STAT

Meta founder Mark Zuckerberg and his wife, pediatrician and philanthropist Priscilla Chan, announced on Wednesday plans to invest $250 million over 10 years to establish a new “biohub” in New York City focused on building a new class of cellular machines that can surveil the body and snuff out disease.

The new initiative, publicly revealed at the 2023 STAT Summit and previewed exclusively to STAT, is the latest program from the Chan Zuckerberg Initiative, or CZI, a company the couple founded in 2015 to help cure, prevent, or manage all disease by 2100. It joins the original San Francisco Biohub founded in 2016 and a Chicago Biohub founded earlier this year.

“About the five-year mark, we basically sat down and tried to assess what we thought was working well and what we want to double down on,” Zuckerberg told STAT. “And we thought that the Biohub model to bring a few universities together, coupling that with engineering and a long-term goal, was a model that was really doing well.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Testing for cancer recurrence creates a new limbo for patients

leisure time

Wikipedia

WSS

The EPA's new lead rule: How one expert crunched the numbers

What don’t we know about an Alzheimer’s drug side effect?

UnitedHealth’s Optum accused of antitrust violations in California

Disappointing trial forces Pfizer to pivot on obesity medicine plans

Diagnostic tests are hitting their mathematical limits

Telehealth options flood the market as retailers push virtual care

focus

leisure time

leisure time

The cancer drug shortage isn’t new — and neither are the solutions

Despite FDA concern, risk that CAR

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Eli Lilly to pay $200M for Beam’s stake in gene

New air purifier tech could be key to improving indoor air quality

The pink breast cancer awareness ribbon needs a redesign

How to save PrEP access — and even expand it

With clinical trial data readouts, here's how to spot spin

Drug repurposing or repositioning? The language matters

CDC recommends rationing of RSV shot due to shortages

explore

With clinical trial data readouts, here's how to spot spin

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

BIO selects John Crowley as new CEO

The FDA weighs the risks of candy

Disappointing trial forces Pfizer to pivot on obesity medicine plans

First Opinion Podcast: How to protect health care in times of war

leisure time

focus

Wikipedia

leisure time